@DiabLabPenn

Asst. Prof. @PennMedicine | @NIDCR K99/R00 Fellow | Cell Cycle | DNA Damage | HPV | TME | head & neck cancer | @fredhutch & @LifeAtPurdue | He | Tweets my own

 Philadelphia, PA
med.upenn.edu/diab-lab/contact-us
Joined January 2011
  • Tweets784
  • Following2.6K
  • Followers1K
41Media
Congratulations to @taabaman (@BB_UPenn) on being named a 2026 @BWFUND Investigator in the Pathogenesis of Infectious Disease (PATH) Awardee! tinyurl.com/3yun8mxw
9
24
1,435
Congratulations to Amulya Sreekumar (@Penn_CBIO) on being named to the @AACR NextGen Stars Class of 2026! tinyurl.com/47aa7vjn
1
3
284
Now published: New study on the controversial role of confirmatory HPV testing in p16+ OPCs 📚 Corresponding author: @BasuLab1 Read more: ascopubs.org/doi/10.1200/PO-… link in our bio 🔗 #AcademicMedicine #Research #HPV #headandneckcancer
1
6
9
1,008
Huge congratulations to Dr Jennifer Douglas @Penn_ENT for her P50 grant with collaborators @ Monell Chemical Senses Center! Incredible accomplishment for this surgeon:scientist star.
1
9
292
It was a privilege to present today at the 9th annual DDR Summit in Boston , representing the @PennCancer team advancing translational science and clinical trials for HPV+ head and neck cancer @DiabLabPenn @DrNickLukens @LovaSunMD
2
1
3
274
I’m coming to New Orleans in April to give a talk and would love to see about bringing our science to other institutions in the area. Anyone have opportunities for this? Hematopoiesis, cancer biology, stem cells, glycans?
1
2
24
3,689
Honored to share our all-in-one CAR-T work for advanced prostate cancer with @zklaassen_md and @urotoday . Grateful for @PCFnews @PCF_Science , @carlhjune & my team. urotoday.com/video-lectures/…
3
17
956
🚨 Calling all postdocs 🚨 We are soliciting applications to our 8th cohort of Fred Hutch Dr. Eddie Méndez Scholars! Awardees will be invited to present at a symposium celebrating their achievements 🧵 Apply here 👇 👇 👇 apply.interfolio.com/176955 📆 Applications due 2/1/2026
1
33
1
103
17,188
I am at #SITC25 . I’m looking for a second postdoc to join my tumor immunology lab at UCSF. So, if you’re graduating soon etc. and here, message me or drop your poster number in the comments!!
1
7
13
2,328
Please Repost: 3 out of 4 adults by age 30 have HPV. In the past 4 years HPV related tongue, throat & tonsil cancer has surpassed cervical cancer & become an epidemic among men between ages 40-60. Let's protect our sons and daughter by leaning about the HPV vaccine. @DrZSB @drsforamerica @DrMarcSiegel @InfoASHA @foxandfriends @ImmunizeOrg @TheJoeySwoll @EricTopol @USRepKCastor @HPVProjectPERCH @JesseBWatters @rfkJrHealth24 @SU2C
1
6
1
5
567
What's the difference between Trm and exhausted CD8 T cells? Simone Park's new work dissects this important question. These cell types are often confused, but are ontologically and mechanistically distinct with implications for immunotherapy responses. biorxiv.org/content/10.1101/…

Divergent ontogeny of Tissue Resident Memory and Tissue Resident Exhausted CD8+ T cells underlies...

Persistent antigen stimulation promotes differentiation of exhausted CD8+ T (TEX) cells. TEX cells are distinct from circulating memory T (TCIRCM) cells but share many features with tissue-resident...

biorxiv.org
1
26
1
117
7,411
Proud of my student, Jidapa Janpathompong, for delivering an outstanding presentation on her summer research at the SUIP Symposium at Penn. Huge thanks to everyone who made this event a success! @RTAatPennMed @parkerici @PennMedicine @bradylabupenn
1
10
616
📢 Just Published! Dr. Douglas’s latest research reveals how chemotherapy-induced taste changes impact nutrition and quality of life. 🔗 Read More: loom.ly/jUJKxfc (#linkinbio) #CancerResearch #SmellandTaste #QualityOfLife #NutritionMatters #Rhinology
3
8
482
Boom!💥 ⁦@FDA⁩ approves neoadjuvant and adjuvant pembrolizumab for resectable locally advanced head and neck squamous cell carcinoma, ushering in a new standard of care for the first time in decades. fda.gov/drugs/resources-info…

FDA approves neoadjuvant and adjuvant pembrolizumab for resectable loc

On June 12, 2025, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) for adults with resectable locally advanced head and neck squamous c

fda.gov
21
36
2,273
Thanks to @NIH-supported research, baby KJ successfully received personalized gene therapy treatment for CPS1, a life-threatening, incurable genetic disease. This marks the first time this technology has been successfully used to treat a human patient.
NIH
@NIH15 May 2025
News: Infant with rare, incurable disease is first to successfully receive personalized gene therapy treatment nih.gov/news-events/news-rel…

Infant with rare, incurable disease is first to successfully receive personalized gene therapy...

NIH-supported gene-editing platform lays groundwork to rapidly develop treatments for other rare genetic diseases.

nih.gov
39
116
10
1,078
78,546
Replying to @AHNSinfo
So proud of this tribute to my dear friend Dr. Eddie Mendez. His profound legacy lives on through the work of these fellows and our society!
1
3
186
The 2024 Young Investigator Awards recipients have just been announced. Congrats to this year’s class, who received $6.3 million in funding for innovative prostate cancer research. Meet this year’s class: bit.ly/YIAwardsClass2024 #ProstateCancer #MedEd #MedX
9
2
36
4,649
Congrats to @EJohnWherry, PhD, Co-Director of the PICI Center at @PennMedicine, on his election to the @theNASciences—one of the highest honors in American science! His discoveries in T cell exhaustion and checkpoint pathways have transformed cancer immunotherapy and continue to shape the field. nasonline.org/news/2025-nas-… #Immunotherapy #CancerImmunotherapy #NASmembers
1
11
1
74
4,591
Job alert! We are looking for postdoc interested in quantitative methods to understand metabolic programming in cancer and immune cells! Also recruiting technician to help manage lab instruments and projects. DM or email me or forward to anyone you think that might be interested!
2
19
2
42
11,360
🚨Finally! @DrUppaluri presents data from Keynote0689 -- anti-PD1 makes it in locally advanced HNSCC -- approximate 10% EFS benefit from Pembro in surgically managed HNSCC. #aacr25 #hncsm
3
19
2
58
11,301
Load more